Found: 8
Select item for more details and to access through your institution.
Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis.
- Published in:
- Life (2075-1729), 2020, v. 10, n. 9, p. 177, doi. 10.3390/life10090177
- By:
- Publication type:
- Article
Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Serum aldo–keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis.
- Published in:
- Journal of Gastroenterology, 2019, v. 54, n. 6, p. 549, doi. 10.1007/s00535-019-01551-3
- By:
- Publication type:
- Article
Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells.
- Published in:
- Cancer Science, 2019, v. 110, n. 4, p. 1364, doi. 10.1111/cas.13971
- By:
- Publication type:
- Article
Serum C16:1n7/C16:0 ratio as a diagnostic marker for non‐alcoholic steatohepatitis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 10, p. 1829, doi. 10.1111/jgh.14654
- By:
- Publication type:
- Article
Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191026
- By:
- Publication type:
- Article